← FDA DRUG APPROVALS

FDA ANDA · ANDA200752

DEXRAZOXANE

Sponsor: EUGIA PHARMA

APPLICATION
ANDA200752
TYPE
ANDA
ORIGINAL APPROVAL
2011-10-19
LATEST ACTION
2015-05-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

DEXRAZOXANE HYDROCHLORIDEPrescription
DEXRAZOXANE HYDROCHLORIDE EQ 250MG BASE/VIAL · INJECTABLE · INJECTION
DEXRAZOXANE HYDROCHLORIDEPrescription
DEXRAZOXANE HYDROCHLORIDE EQ 500MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2015-05-19Labeling · Supplement 4 · standardAP
2015-05-19Labeling · Supplement 2 · standardAP
2011-10-19Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →